- Ars Medical specialises in oncology, haematology, cardiology, internal medicine and palliative care
- Abris Capital acquired Scanmed in November 2020
- The acquisition will expand the company’s presence in north-west Poland
Abris Capital Partners announced its portfolio company Scanmed, a Polish healthcare business, is acquiring Ars Medical.
Ars Medical, based in Piła, Poland, specialises in oncology, haematology, cardiology, internal medicine and palliative care, as well as general and specialist outpatient care. The company has a team of 400 doctors and nurses, including over 100 specialists in 48 therapeutic areas.
Abris acquired Warsaw-headquartered private healthcare provider Scanmed in November 2020. According to Abris, the add-on acquisition has “strong strategic rationale” as it will enable synergies with existing Scanmed facilities and expand the company’s presence in north-west Poland.
“The acquisition of Ars Medical is the latest step in our ambitious buy-and-build strategy for Scanmed,” said Sylwester Urbanek, investment director at Abris Capital Partners. “We welcome the Ars Medical team on board and we will continue supporting Scanmed’s development and the constant improvement of quality of care in key therapeutic areas.”
Warsaw-based Abris’ previous investments in the healthcare sector include Matexlab, a Swiss vendor of aesthetic medicine products, and Dentotal Protect, a distributor of dental consumables, instruments and equipment in Romania and Bulgaria.